Drug archive
Halofantrine (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antimalarial
Description
Halofantrine (ha-loe-FAN-trin) belongs to a group of medicines known as antimalarials. It is used to treat malaria, a red blood cell infection transmitted by the bite of a mosquito.
Malaria transmission occurs in large areas of Central and South America, Hispaniola, sub-Saharan Africa, the Indian subcontinent, Southeast Asia, the Middle East, and Oceania. Country-specific information on malaria can be obtained from the Centers for Disease Control and Prevention (CDC) or from the CDC's web site at http://www.cdc.gov/travel/yellowbk .
This medicine may cause serious side effects. Therefore, it usually is used to treat serious malaria infections in areas where it is known that other medicines may not work.
Halofantrine is available only with your doctor's prescription, in the following dosage forms:
- Oral suspension (United Kingdom)
- Tablets (U.S. and United Kingdom)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Halfan
† Not commercially available in Canada.